Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype

[1]  A. Lampen,et al.  Risks and benefits of dietary isoflavones for cancer , 2011, Critical reviews in toxicology.

[2]  Y. Ahn,et al.  A prospective study investigating the association between environmental tobacco smoke exposure and the incidence of type 2 diabetes in never smokers. , 2011, Annals of epidemiology.

[3]  K. Setchell,et al.  Equol: pharmacokinetics and biological actions. , 2010, The Journal of nutrition.

[4]  P. Gaulard,et al.  Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. , 2010, Blood.

[5]  D. Kwon,et al.  Antidiabetic effects of fermented soybean products on type 2 diabetes. , 2010, Nutrition research.

[6]  K. Koehler,et al.  The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women. , 2010, The American journal of clinical nutrition.

[7]  Andrew D. Johnson,et al.  Genome-wide association study of blood pressure and hypertension , 2009, Nature Genetics.

[8]  Taesung Park,et al.  A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits , 2009, Nature Genetics.

[9]  F. Branca,et al.  Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. , 2008, The American journal of clinical nutrition.

[10]  R. Katoh,et al.  Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials. , 2008, Clinical nutrition.

[11]  Qiong Yang,et al.  A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study , 2007, BMC Medical Genetics.

[12]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[13]  P. Sorensen,et al.  The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers , 2007, Nature Medicine.

[14]  Xin Liu,et al.  Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health. , 2007, Molecular nutrition & food research.

[15]  T. Clarkson,et al.  Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: lack of effect of soy supplementation , 2007, Climacteric : the journal of the International Menopause Society.

[16]  Clifford A. Meyer,et al.  Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.

[17]  F. Shanahan,et al.  The gut flora as a forgotten organ , 2006, EMBO reports.

[18]  J. Lampe,et al.  Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. , 2006, The Journal of nutrition.

[19]  Terence P. Speed,et al.  Genome analysis A genotype calling algorithm for affymetrix SNP arrays , 2005 .

[20]  J. Lampe,et al.  Gut Bacterial Metabolism of the Soy Isoflavone Daidzein: Exploring the Relevance to Human Health , 2005, Experimental biology and medicine.

[21]  Nataliya Melnyk,et al.  Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney. , 2004, Human molecular genetics.

[22]  J. Lampe,et al.  In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. , 2004, The Journal of nutrition.

[23]  A. Pantuck,et al.  Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. , 2004, Japanese journal of clinical oncology.

[24]  T. Miki,et al.  Serum phytoestrogens and prostate cancer risk in a nested case‐control study among Japanese men , 2004, Cancer science.

[25]  Yiwei Li,et al.  Mechanisms of Cancer Chemoprevention by Soy Isoflavone Genistein , 2004, Cancer and Metastasis Reviews.

[26]  S. Bingham,et al.  Quantification of isoflavones and lignans in serum using isotope dilution liquid chromatography/tandem mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.

[27]  N. Nowak,et al.  Molecular analysis of region t(5;6)(q21;q21) in Wilms tumor. , 2003, Cancer genetics and cytogenetics.

[28]  K. Setchell,et al.  The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. , 2002, The Journal of nutrition.

[29]  X. Shu,et al.  Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  N. Miyanaga,et al.  Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration. , 2002, Japanese journal of clinical oncology.

[31]  T. Clarkson.  Soy, soy phytoestrogens and cardiovascular disease. , 2002, The Journal of nutrition.

[32]  S. Barnes,et al.  Gaining insight into the health effects of soy but a long way still to go: commentary on the fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease. , 2002, The Journal of nutrition.

[33]  J. Jameson,et al.  Estrogen Receptor Binding to DNA Is Not Required for Its Activity through the Nonclassical AP1 Pathway* , 2001, The Journal of Biological Chemistry.

[34]  H. C. Wang,et al.  Immune function of thyroid stimulating hormone and receptor. , 2001, Critical reviews in immunology.

[35]  H. Adlercreutz,et al.  Identification of isoflavone metabolites dihydrodaidzein, dihydrogenistein, 6'-OH-O-dma, and cis-4-OH-equol in human urine by gas chromatography-mass spectroscopy using authentic reference compounds. , 1999, Analytical biochemistry.

[36]  D. DellaPenna,et al.  Nutritional genomics: manipulating plant micronutrients to improve human health. , 1999, Science.

[37]  T. Sanders,et al.  Metabolism of oestrogens and phytoestrogens: role of the gut microflora. , 1999, Biochemical Society transactions.

[38]  K. Setchell,et al.  Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. , 1998, The American journal of clinical nutrition.